Refine Search
(7)
(9)
(9)
(9)

Ophthalmology

Research commissioned by Anglia Ruskin University estimates that in all, 217 million people were living with severe or moderate visual impairment in 2015 and the number of people with visual impairment is set to triple by 2050. With increase in average life expectancy, the demand from geriatric population for the treatment of leading eye disorders such as glaucoma and diabetic retinopathy is likely to increase, necessitating intense research efforts to meet the growing need.

Uveitis - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2018’, provides an overview of the Uveitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysi...

Glaucoma - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2018’, provides an overview of the Glaucoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with anal...

Bacterial Conjunctivitis - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacterial Conjunctivitis - Pipeline Review, H1 2018’, provides an overview of the Bacterial Conjunctivitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Ocular Hypertension - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2018’, provides an overview of the Ocular Hypertension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ocular...

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2018’, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) pipeline landscape.

The report provides comprehensive ...

Optic Neuropathy - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Optic Neuropathy - Pipeline Review, H1 2018’, provides an overview of the Optic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Optic Neurop...

Viral Conjunctivitis - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Viral Conjunctivitis - Pipeline Review, H1 2018’, provides an overview of the Viral Conjunctivitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vira...

Age Related Macular Degeneration - Pipeline Review, H2 2017

  • $2,000
  • December 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H2 2017’, provides an overview of the Age Related Macular Degeneration pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Macular Edema - Pipeline Review, H2 2017

  • $2,000
  • November 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Macular Edema - Pipeline Review, H2 2017’, provides an overview of the Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Macular Edema, com...